Glenmark Naproxen Sodium Tablets recalled for CGMP deviations
Glenmark Pharmaceuticals is recalling 9,552 bottles of Naproxen Sodium Tablets USP 275 mg nationwide due to CGMP (current Good Manufacturing Practice) deviations identified at the manufacturing facility.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall for CGMP deviations. The source text does not report any illnesses, injuries, or adverse events; the hazard is compliance-related manufacturing practice, not product harm. Per the rubric, Class II recalls without reported illness or injury are rated 2 (Moderate).
Plain-English summary
Glenmark Pharmaceuticals Inc., USA is recalling Naproxen Sodium Tablets, USP 275 mg (100 tablets per bottle, NDC 68462-178-01) due to CGMP deviations. The recall affects 9,552 bottles distributed nationwide.
The affected lots are: 29190087 (Exp. 10/31/2021), 29190088 (Exp. 10/31/2021), 29190089 (Exp. 10/31/2021), 29200077 (Exp. 11/30/2022), and 29200078 (Exp. 11/30/2022). The product is manufactured by Glenmark Pharmaceuticals Inc., USA at 4147 Goldmine Road, Monroe, NC 28110.
The recall is voluntary and was initiated by the firm on August 27, 2021, following FDA notification of CGMP deviations at the manufacturing facility. This is a Class II recall. Patients taking this medication should consult their healthcare provider or pharmacist about whether to continue use or obtain replacement product from an alternative source.
The recalled product
- Product
- NAPROXEN SODIUM (NAPROXEN SODIUM)
- Brand
- NAPROXEN SODIUM
- Manufacturer
- Glenmark Pharmaceuticals Inc., USA
- Category
- Drug — Prescription NSAID
- Hazard
- cgmp-deviation
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lots: 29190087 Exp. 10/31/2021
- 29190088 Exp. 10/31/2021
- 29190089 Exp. 10/31/2021
- 29200077 Exp. 11/30/2022
- 29200078 Exo
- 11/30/2022
UPCs (5)
- 0368462189016
- 0368462178010
- 0368462179017
- 0368462188019
- 0368462190012
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · NAPROXEN SODIUM
- ModeratePrescription Naproxen Sodium tablets recalled for manufacturing deviations
FDA (Drugs) · 2025-04-16
- HighPrescription Naproxen 250mg tablets recalled for labeling mix-up with indomethacin
FDA (Drugs) · 2023-12-06
- ModerateGlenmark Naproxen Sodium 550 mg Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2021-09-29
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27